Lataa...

Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?

Abstract. In 2005, a seminal paper showed that glioblastoma patients aged 18 to 70, whose tumors have a methylated MGMT promoter have a better prognosis than patients with tumors carrying an unmethylated MGMT promoter. As a consequence of this and several confirmatory studies, routine MGMT testing i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Berghoff, Anna S., Preusser, Matthias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dustri-Verlag Dr. Karl Feistle 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3663470/
https://ncbi.nlm.nih.gov/pubmed/23083460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300576
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!